RFG
GSK icon

REAP Financial Group’s GSK GSK Stock Holding History

REAP Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-96
Closed -$3.72K – 529
2025
Q1 		$3.72K Buy
96
+55
+134% +$2.01K ﹤0.01% 453
2024
Q4 		$1.37K Sell
41
-93
-69% -$3.35K ﹤0.01% 523
2024
Q3 		$5.48K Buy
+134
New +$5.48K ﹤0.01% 440

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

REAP Financial Group's GSK Position: Q2 2025 in Review

REAP Financial Group sold out of GSK (GSK) in Q2 2025, closing a stake of 96 shares — an estimated $3.72K sold.

REAP Financial Group first reported a position in GSK in Q3 2024 and held it in 3 quarters. The position peaked at $5.48K in Q3 2024. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • REAP Financial Group reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
  • REAP Financial Group sold 96 GSK shares in Q2 2025, an estimated $3.72K.
  • REAP Financial Group first reported a position in GSK in Q3 2024 and held it in 3 quarters.
  • REAP Financial Group's GSK position peaked at $5.48K in Q3 2024.
  • 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on REAP Financial Group's 13F filing for Q2 2025, filed 23 Jul 2025.